Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
01-Apr-2025 | 470.55 | 480.15 | 465.5 | 472.8 | 9,898 | 8,42,80,540.15 | 1,04,766 |
02-Apr-2025 | 470.15 | 476.5 | 461 | 473.9 | 10,661 | 7,00,12,887.4 | 70,736 |
03-Apr-2025 | 479.95 | 496.65 | 472.1 | 476.2 | 9,309 | 13,06,16,148.2 | 1,02,332 |
04-Apr-2025 | 473.55 | 474.95 | 440.55 | 448.85 | 14,810 | 16,37,72,967.55 | 1,61,357 |
07-Apr-2025 | 423 | 438.3 | 405 | 421.4 | 30,737 | 72,11,28,971.05 | 13,39,522 |
08-Apr-2025 | 438 | 462.9 | 424.25 | 446.1 | 37,132 | 71,64,05,331.6 | 8,60,867 |
09-Apr-2025 | 446 | 446 | 423.05 | 428.85 | 15,553 | 14,14,02,448.5 | 1,51,842 |
11-Apr-2025 | 454.2 | 454.2 | 432 | 433.8 | 11,237 | 11,07,20,284.95 | 91,791 |
15-Apr-2025 | 439.95 | 477.15 | 435.8 | 477.15 | 27,545 | 57,50,92,407.2 | 3,33,142 |
16-Apr-2025 | 477.15 | 504.4 | 474.6 | 499.15 | 22,185 | 38,00,72,286 | 2,27,412 |
17-Apr-2025 | 501 | 501 | 481 | 486.35 | 9,832 | 14,17,56,048.05 | 1,39,458 |
21-Apr-2025 | 483 | 508.85 | 479.2 | 501.2 | 14,247 | 18,34,12,889.3 | 1,82,495 |
22-Apr-2025 | 509.55 | 511.6 | 496.6 | 505.95 | 11,568 | 9,93,56,253.85 | 89,773 |
23-Apr-2025 | 506.5 | 513.1 | 495 | 505.65 | 8,913 | 9,11,09,494.15 | 76,704 |
24-Apr-2025 | 508 | 536.95 | 507.1 | 529.95 | 17,038 | 22,43,11,555.3 | 1,67,204 |
25-Apr-2025 | 535 | 543 | 510 | 530.6 | 19,270 | 28,01,63,189.15 | 2,24,192 |
28-Apr-2025 | 530.5 | 544.7 | 521.05 | 524.5 | 10,784 | 10,77,74,797.85 | 84,867 |
29-Apr-2025 | 522.1 | 534.25 | 518 | 524.45 | 6,154 | 5,95,45,397.1 | 40,627 |
The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.
The IPO comprised a fresh issue of shares worth ₹680 crore and an offer-for-sale (OFS) of 1.73 crore shares, aggregating ₹1,177 crore.
The IPO consists of a fresh issue of ₹680 crore and an offer for sale (OFS) of up to 1.73 crore shares at a face value of ₹2 each.
On Monday, the business said that it had received ₹829 crore from anchor investors ahead of the public share sale subscription period.
The IPO includes a new issue of 1 Crore shares worth ₹680.00 Crore and an offer for sale of 1.73 Crore shares worth ₹1,176.74 Crore.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
